Barclays Downgrades Covidien Ltd (COV) to Equalweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
BTIG Upgrades Medtronic, Inc. (MDT) to Buy
June 17, 2014 8:21 AM EDTBTIG upgraded Medtronic, Inc. (NYSE: MDT) from Neutral to Buy with a price target of $73.00. The change follows news it plans to acquire Covidien (NYSE: COV).
Analyst Sean Lavin said,... More
BMO Capital Downgrades Covidien Ltd (COV) to Market Perform
June 17, 2014 7:36 AM EDTBMO Capital downgraded Covidien Ltd (NYSE: COV) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Covidien Ltd click here. For more ratings news on Covidien Ltd click here.
Shares of Covidien Ltd closed at $86.75 yesterday.
... MoreCRT Capital Downgrades Covidien Ltd (COV) to Fairly Valued
June 16, 2014 12:46 PM EDTCRT Capital downgraded Covidien Ltd (NYSE: COV) from Buy to Fairly Valued.
For an analyst ratings summary and ratings history on Covidien Ltd click here. For more ratings news on Covidien Ltd click here.
Shares of Covidien Ltd closed at $72.02 yesterday.
... MoreNeedham & Company Comments on Sector Implications Amid Medtronic (MDT)/Covidien (COV) Megadeal
June 16, 2014 7:30 AM EDTNeedham & Company analyst Mike Matson comments on the sector implications amid Medtronic's (NYSE: MDT) $42.9 billion deal to acquire Covidien (NYSE: COV).
The analyst said while the media is likely to focus on the tax inversion angle, which is certainly playing a role, they... More
William Blair Downgrades Covidien Ltd (COV) to Market Perform
June 16, 2014 7:18 AM EDTWilliam Blair downgraded Covidien Ltd (NYSE: COV) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Covidien Ltd click here. For more ratings news on Covidien Ltd click here.
Shares of Covidien Ltd closed at $72.02 yesterday.
... MoreUPDATE: JPMorgan Upgrades Medtronic, Inc. (MDT) to Overweight
June 16, 2014 6:59 AM EDT(Updated - June 16, 2014 11:35 AM EDT)
JPMorgan upgraded Medtronic, Inc. (NYSE: MDT) from Neutral to Overweight with a price target of $78.00 (from $64.00). The upgrade follows Medtronics agreement to acquire Covidien (NYSE: COV).
Analyst Michael... More
Medtronic (MDT) to Acquire Covidien (COV) in $42.9B Deal
June 16, 2014 6:12 AM EDTMedtronic, Inc. (NYSE: MDT), a global leader in medical technology, services and solutions, and Covidien plc (NYSE: COV), a global healthcare technology and medical supplies provider, today announced that they have entered into a definitive agreement under which Medtronic has agreed to acquire Covidien in a cash-and-stock transaction valued at $93.22 per Covidien share, or a total of approximately $42.9 billion, based on Medtronic`s closing stock price of $60.70 per share on June 13, 2014.
Once the transaction is completed, Medtronic will have significantly advanced its position as the world`s premier... More
